Percheron Therapeutics Ltd (ATHJF)
0.01
0.00 (0.00%)
USD |
OTCM |
May 10, 16:00
Percheron Therapeutics Total Liabilities (Quarterly): 2.406M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.406M |
June 30, 2023 | 1.898M |
December 31, 2022 | 1.419M |
June 30, 2022 | 0.891M |
December 31, 2021 | 0.8286M |
June 30, 2021 | 0.9565M |
December 31, 2020 | 0.7685M |
June 30, 2020 | 0.5643M |
December 31, 2019 | 1.074M |
June 30, 2019 | 0.6225M |
December 31, 2018 | 0.3645M |
June 30, 2018 | 0.4267M |
December 31, 2017 | 0.2621M |
June 30, 2017 | 0.5269M |
December 31, 2016 | 0.4139M |
June 30, 2016 | 0.5602M |
December 31, 2015 | 0.3708M |
June 30, 2015 | 0.446M |
December 31, 2014 | 0.4581M |
June 30, 2014 | 0.5358M |
December 31, 2013 | 0.5801M |
June 30, 2013 | 0.5141M |
December 31, 2012 | 0.5843M |
Date | Value |
---|---|
June 30, 2012 | 0.4247M |
December 31, 2011 | 0.4094M |
June 30, 2011 | 0.4465M |
December 31, 2010 | 0.352M |
June 30, 2010 | 0.3965M |
December 31, 2009 | 0.457M |
June 30, 2009 | 0.8556M |
December 31, 2008 | 0.7495M |
June 30, 2008 | 3.381M |
December 31, 2007 | 2.389M |
June 30, 2007 | 1.723M |
December 31, 2006 | 0.4593M |
June 30, 2006 | 0.2397M |
December 31, 2005 | 0.4368M |
June 30, 2005 | 0.2726M |
December 31, 2004 | 0.4913M |
June 30, 2004 | 0.7094M |
December 31, 2003 | 0.1805M |
June 30, 2003 | 0.2452M |
December 31, 2002 | 1.056M |
June 30, 2002 | 1.043M |
December 31, 2001 | 2.978M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.5643M
Minimum
Jun 2020
2.406M
Maximum
Dec 2023
1.143M
Average
0.9238M
Median
Total Liabilities (Quarterly) Benchmarks
Alterity Therapeutics Ltd | 2.345M |
Kazia Therapeutics Ltd | 13.02M |
Immutep Ltd | 9.137M |
Opthea Ltd | 213.41M |
Mesoblast Ltd | 167.58M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 13.61M |
Shareholders Equity (Quarterly) | 11.21M |